Fingerprint
Dive into the research topics of 'Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer
Dana Rathkopf, Glenn Liu, Michael A. Carducci, Mario A. Eisenberger, Aseem Anand, Michael J. Morris, Susan F. Slovin, Yasutsuna Sasaki, Shunji Takahashi, Seiichiro Ozono, Nga Kit Eliza Fung, Shinta Cheng, Jinping Gan, Marco Gottardis, Mary T. Obermeier, Jyotsna Reddy, Steven Zhang, Blisse J. Vakkalagadda, Leila Alland, George Wilding
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations